SEC CIK 1501808
Weymouth Katharine
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GHCview stock → | 7,615 | 2026-05-26 |
| CABOview stock → | 5,195 | 2026-05-14 |
Position History — CABO
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CABO
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-14 | Grant / award | 3,031 | $51.13 | 5,195 |
| 2025-06-16 | Open-market buy | 150 | $130.88 | 2,294 |
| 2025-05-15 | Grant / award | 941 | $164.70 | 2,144 |
| 2024-05-16 | Grant / award | 392 | $395.36 | 1,203 |
| 2023-05-19 | Grant / award | 233 | $665.00 | 811 |
| 2022-05-20 | Grant / award | 130 | $0.00 | 578 |
| 2021-05-21 | Grant / award | 70 | $0.00 | 448 |
| 2020-12-11 | Open-market sale | 27 | $2110.50 | 378 |
| 2020-05-15 | Grant / award | 68 | $0.00 | 405 |
| 2019-11-18 | Open-market sale | 228 | $1509.50 | 337 |
| 2019-05-17 | Grant / award | 109 | $0.00 | 565 |
| 2019-05-08 | Option exercise (derivative) | 201 | $0.00 | 0 |
| 2019-05-08 | Option exercise | 201 | — | 456 |
| 2018-08-31 | Open-market sale | 254 | $834.30 | 255 |
| 2018-05-08 | Grant / award (derivative) | 201 | $0.00 | 201 |
| 2018-05-02 | Option exercise (derivative) | 184 | $0.00 | 0 |
| 2018-05-02 | Option exercise | 184 | — | 5,230 |
| 2017-05-03 | Option exercise (derivative) | 325 | $0.00 | 0 |
| 2017-05-03 | Option exercise | 325 | — | 5,046 |
| 2017-05-02 | Grant / award (derivative) | 184 | $0.00 | 184 |
| 2017-03-06 | Open-market sale | 636 | $631.10 | 4,721 |
| 2017-03-06 | Open-market sale | 563 | $627.55 | 6,732 |
| 2017-03-06 | Open-market sale | 139 | $628.66 | 6,593 |
| 2017-03-06 | Open-market sale | 658 | $629.27 | 5,935 |
| 2017-03-06 | Open-market sale | 1,562 | $625.07 | 8,159 |
| 2017-03-06 | Open-market sale | 864 | $626.34 | 7,295 |
| 2017-03-06 | Open-market sale | 578 | $630.00 | 5,357 |
| 2016-05-24 | Open-market sale | 430 | $484.92 | 9,721 |
| 2016-05-03 | Grant / award (derivative) | 325 | $0.00 | 325 |
| 2016-05-03 | Option exercise (derivative) | 430 | $0.00 | 0 |
| 2016-05-03 | Option exercise | 430 | — | 10,151 |
| 2016-03-24 | Open-market sale | 841 | $435.03 | 9,721 |
| 2016-03-22 | Open-market sale | 300 | $440.29 | 10,562 |
| 2016-03-21 | Open-market sale | 401 | $440.00 | 10,862 |
| 2016-03-17 | Open-market sale | 79 | $440.00 | 11,263 |
| 2016-03-16 | Open-market sale | 242 | $440.00 | 11,342 |
| 2016-03-15 | Open-market sale | 637 | $440.01 | 11,584 |
| 2016-03-04 | Grant / award (derivative) | 1 | $0.00 | 430 |
| 2015-12-17 | Open-market sale | 706 | $425.00 | 14,015 |
| 2015-12-17 | Open-market sale | 92 | $437.78 | 12,221 |
| 2015-12-17 | Open-market sale | 752 | $435.00 | 12,313 |
| 2015-12-17 | Open-market sale | 100 | $432.11 | 13,065 |
| 2015-12-17 | Open-market sale | 650 | $430.12 | 13,165 |
| 2015-12-17 | Open-market sale | 200 | $428.00 | 13,815 |
| 2015-12-04 | Grant / award (derivative) | 1 | $0.00 | 429 |
| 2015-08-04 | Grant / award (derivative) | 428 | $0.00 | 428 |
| 2015-07-01 | — | — | — | 14,721 |
| 2015-07-01 | — | — | — | 10,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.